AI’s Approaches to Maternal and Neonatal Health in Low Resource Settings

By Sumona Bose

December 23, 2023

Introduction

A significant challenge faced by hospitals and medical practitioners in low- and middle-income countries is the lack of sufficient healthcare facilities for timely medical diagnosis of chronic and deadly diseases. Maternal and neonatal morbidity due to non-communicable and nutrition-related diseases is a serious public health issue that leads to several deaths every year. Detecting these conditions at their early stages is challenging, putting patients at risk of developing severe conditions over time. However, the advent of Artificial Intelligence (AI) has opened up new possibilities for improving maternal and neonatal health. This article will give an overview on AI’s Approaches to Maternal and Neonatal Health in Low Resource Settings.

AI holds Promise for Maternal and Neonatal Health

AI has emerged as a practical assistive tool in various healthcare sectors, but its application in maternal and neonatal health is still in its nascent stages. One example of how AI can be used in low-resource settings is in maternal health and diagnostics services. In these settings, access to proper healthcare infrastructure and professionals is limited, making it difficult to provide holistic care to pregnant women and their children. However, AI technologies such as digital chatbots and support groups can aid in maternal and neonatal health monitoring and management. These technologies can engage users in follow-up questions about their health in their desired language, helping to disperse basic health information.

Figure 1: Focus Areas on Role of AI in complimenting maternal health

 

Challenges and Solutions for AI

Explainable Artificial Intelligence (XAI) or Dependable AI (DAI) can provide insights into the decision-making process of AI models. This level of explainability increases the confidence that medical practitioners and AI researchers have in the system, leading to broader adoption of AI in the healthcare field. By understanding why someone has been classified as ill or otherwise, the perception of AI models as a “black box” can be changed, making them more scalable and employable. XAI can be merged with smart healthcare systems that incorporate the Internet of Things, cloud computing, and AI, particularly in the fields of maternal and neonatal health. These intelligent healthcare systems can be utilized for various purposes, including disease diagnosis and treatment selection.

In some crucial small sample size healthcare problems where large datasets are not available, Few-shot learning or Zero-shot learning can be used to train AI models. These learning frameworks utilize domain information to reach medical decisions or predictions, making them efficient tools for doctors to handle rare medical conditions and problems that require years of experience.

Conclusion

Improving maternal and newborn health requires bringing speedy diagnosis and treatment to point-of-care settings in developing nations with limited resources.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.